Morgan Stanley’s CNOVA N.V. CNV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q1
Sell
-3,478,453
Closed -$19.1M 6711
2016
Q4
$19.1M Buy
3,478,453
+1,798,999
+107% +$9.78M 0.01% 1579
2016
Q3
$9.02M Buy
1,679,454
+1,042,828
+164% +$5.37M ﹤0.01% 2103
2016
Q2
$3.15M Buy
636,626
+451,387
+244% +$1.91M ﹤0.01% 3034
2016
Q1
$556K Buy
185,239
+86,246
+87% +$207K ﹤0.01% 4370
2015
Q4
$239K Sell
98,993
-13,235
-12% -$38.2K ﹤0.01% 4996
2015
Q3
$338K Sell
112,228
-39,403
-26% -$184K ﹤0.01% 4823
2015
Q2
$838K Sell
151,631
-44,246
-23% -$264K ﹤0.01% 4336
2015
Q1
$1.23M Sell
195,877
-459,929
-70% -$3.03M ﹤0.01% 3967
2014
Q4
$5.19M Buy
+655,806
New +$4.73M ﹤0.01% 2703

Other funds holding CNV

Morgan Stanley's CNV Position: Q1 2017 in Review

Morgan Stanley sold out of CNOVA N.V. (CNV) in Q1 2017, closing a stake of 3,478,453 shares — an estimated $19.1M sold.

Morgan Stanley first reported a position in CNV in Q4 2014 and held it in 9 quarters. The position peaked at $19.1M in Q4 2016. 2 funds tracked by Wall St. Rank hold CNV as of Q1 2017.

  • Morgan Stanley reported no remaining CNOVA N.V. position as of Q1 2017 after selling out during the quarter.
  • Morgan Stanley sold 3,478,453 CNOVA N.V. shares in Q1 2017, an estimated $19.1M.
  • Morgan Stanley first reported a position in CNOVA N.V. in Q4 2014 and held it in 9 quarters.
  • Morgan Stanley's CNOVA N.V. position peaked at $19.1M in Q4 2016.
  • 2 funds tracked by Wall St. Rank held CNOVA N.V. as of Q1 2017.

Based on Morgan Stanley's 13F filing for Q1 2017, filed 12 May 2017.